Drug Shortage Report for SODIUM ACETATE INJECTION USP
| Report ID | 252444 |
| Drug Identification Number | 02181746 |
| Brand name | SODIUM ACETATE INJECTION USP |
| Common or Proper name | SODIUM ACETATE INJECTION USP |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM ACETATE |
| Strength(s) | 328MG |
| Dosage form(s) | SOLUTION LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 x 50mL vial / fiole |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-02-28 |
| Estimated end date | 2025-04-01 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-03-13 |
| Company comments | Labelling issue |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-03-13 | French | Compare |
| v1 | 2025-03-13 | English | Compare |
Showing 1 to 2 of 2